GNLX
Price
$2.37
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
53 days until earnings call
SNSE
Price
$0.49
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
46 days until earnings call
Ad is loading...

GNLX vs SNSE

Header iconGNLX vs SNSE Comparison
Open Charts GNLX vs SNSEBanner chart's image
Genelux
Price$2.37
Change-$0.00 (-0.00%)
Volume$54.46K
CapitalizationN/A
Sensei Biotherapeutics
Price$0.49
Change-$0.00 (-0.00%)
Volume$379.09K
CapitalizationN/A
View a ticker or compare two or three
GNLX vs SNSE Comparison Chart
Loading...
GNLX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SNSE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
GNLX vs. SNSE commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNLX is a Hold and SNSE is a Hold.

COMPARISON
Comparison
Sep 21, 2024
Stock price -- (GNLX: $2.45 vs. SNSE: $0.49)
Brand notoriety: GNLX and SNSE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GNLX: 36% vs. SNSE: 579%
Market capitalization -- GNLX: $81.85M vs. SNSE: $12.97M
GNLX [@Biotechnology] is valued at $81.85M. SNSE’s [@Biotechnology] market capitalization is $12.97M. The market cap for tickers in the [@Biotechnology] industry ranges from $595.57B to $0. The average market capitalization across the [@Biotechnology] industry is $2.99B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GNLX’s FA Score shows that 0 FA rating(s) are green whileSNSE’s FA Score has 1 green FA rating(s).

  • GNLX’s FA Score: 0 green, 5 red.
  • SNSE’s FA Score: 1 green, 4 red.
According to our system of comparison, SNSE is a better buy in the long-term than GNLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GNLX’s TA Score shows that 5 TA indicator(s) are bullish while SNSE’s TA Score has 3 bullish TA indicator(s).

  • GNLX’s TA Score: 5 bullish, 5 bearish.
  • SNSE’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, GNLX is a better buy in the short-term than SNSE.

Price Growth

GNLX (@Biotechnology) experienced а -5.77% price change this week, while SNSE (@Biotechnology) price change was -2.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.40%. For the same industry, the average monthly price growth was +1.46%, and the average quarterly price growth was -0.90%.

Reported Earning Dates

GNLX is expected to report earnings on Nov 12, 2024.

SNSE is expected to report earnings on Nov 05, 2024.

Industries' Descriptions

@Biotechnology (+0.40% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GNLX($81.8M) has a higher market cap than SNSE($13M). SNSE YTD gains are higher at: -29.812 vs. GNLX (-82.512). GNLX has higher annual earnings (EBITDA): -25.61M vs. SNSE (-28.24M). SNSE has more cash in the bank: 52.3M vs. GNLX (33.6M). GNLX has less debt than SNSE: GNLX (2.21M) vs SNSE (5.05M). GNLX has higher revenues than SNSE: GNLX (8K) vs SNSE (0).
GNLXSNSEGNLX / SNSE
Capitalization81.8M13M629%
EBITDA-25.61M-28.24M91%
Gain YTD-82.512-29.812277%
P/E RatioN/AN/A-
Revenue8K0-
Total Cash33.6M52.3M64%
Total Debt2.21M5.05M44%
TECHNICAL ANALYSIS
Technical Analysis
GNLXSNSE
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
76%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 9 days ago
88%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 17 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
GNLX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SNSE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CG42.320.33
+0.79%
Carlyle Group (The)
INST23.540.02
+0.09%
Instructure Holdings
NEON11.73-0.19
-1.59%
Neonode
RDWR21.41-0.55
-2.50%
Radware Ltd
BRTX1.65-0.10
-5.71%
BioRestorative Therapies

GNLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, GNLX has been loosely correlated with VSTM. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if GNLX jumps, then VSTM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNLX
1D Price
Change %
GNLX100%
-3.54%
VSTM - GNLX
47%
Loosely correlated
-2.52%
SNSE - GNLX
31%
Poorly correlated
-5.69%
KRYS - GNLX
29%
Poorly correlated
-3.44%
PRME - GNLX
26%
Poorly correlated
-0.50%
QSI - GNLX
26%
Poorly correlated
+2.03%
More

SNSE and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNSE has been loosely correlated with VSTM. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if SNSE jumps, then VSTM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNSE
1D Price
Change %
SNSE100%
-5.69%
VSTM - SNSE
48%
Loosely correlated
-2.52%
ALZN - SNSE
40%
Loosely correlated
+2.98%
FATE - SNSE
36%
Loosely correlated
-3.00%
GOSS - SNSE
34%
Loosely correlated
+1.38%
ORMP - SNSE
32%
Poorly correlated
-3.59%
More